Loading...
Amgen Inc.
AMGN•NASDAQ
HealthcareDrug Manufacturers - General
$290.33
$3.23(1.13%)
Amgen Inc. (AMGN) Financial Performance & Statements
Review Amgen Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
18.57%
↑ 18.57%
Operating Income Growth
-8.09%
↓ 8.09%
Net Income Growth
-39.11%
↓ 39.11%
Operating Cash Flow Growth
35.64%
↑ 35.64%
Operating Margin
21.82%
↑ 21.82%
Gross Margin
63.002%
↑ 63.002%
Net Profit Margin
17.39%
↑ 17.39%
ROE
92.94%
↑ 92.94%
ROIC
11.22%
↑ 11.22%
Amgen Inc. (AMGN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Amgen Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $9.09B | $8.50B | $8.39B | $7.45B |
| Cost of Revenue | $3.11B | $3.31B | $3.24B | $3.20B |
| Gross Profit | $5.97B | $5.19B | $5.15B | $4.25B |
| Gross Profit Ratio | $0.66 | $0.61 | $0.61 | $0.57 |
| R&D Expenses | $1.72B | $1.45B | $1.45B | $1.34B |
| SG&A Expenses | $1.88B | $1.63B | $1.78B | $1.81B |
| Operating Expenses | $3.66B | $3.15B | $3.24B | $3.26B |
| Total Costs & Expenses | $6.78B | $6.46B | $6.48B | $6.46B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $747.00M | $776.00M | $808.00M | $824.00M |
| Depreciation & Amortization | $1.40B | $1.40B | $1.40B | $1.40B |
| EBITDA | $2.93B | $5.27B | $3.002B | $2.15B |
| EBITDA Ratio | $0.32 | $0.62 | $0.36 | $0.29 |
| Operating Income | $2.31B | $2.05B | $1.91B | $991.00M |
| Operating Income Ratio | $0.25 | $0.24 | $0.23 | $0.13 |
| Other Income/Expenses (Net) | -$1.53B | $1.05B | -$1.11B | -$1.06B |
| Income Before Tax | $782.00M | $3.10B | $794.00M | -$68.00M |
| Income Before Tax Ratio | $0.09 | $0.36 | $0.09 | -$0.009 |
| Income Tax Expense | $155.00M | $271.00M | $48.00M | $45.00M |
| Net Income | $627.00M | $2.83B | $746.00M | -$113.00M |
| Net Income Ratio | $0.07 | $0.33 | $0.09 | -$0.02 |
| EPS | $1.16 | $5.27 | $1.39 | -$0.21 |
| Diluted EPS | $1.16 | $5.22 | $1.38 | -$0.21 |
| Weighted Avg Shares Outstanding | $540.52M | $537.00M | $537.00M | $536.00M |
| Weighted Avg Shares Outstanding (Diluted) | $542.00M | $542.00M | $541.00M | $536.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan